Q. ERM protein moesin is phosphorylated by advanced glycation end products and modulates endothelial permeability. Am J Physiol Heart Circ Physiol 297: H238 -H246, 2009. First published April 24, 2009 doi:10.1152/ajpheart.00196.2009.-Advanced glycation end products (AGEs) accumulated in different pathological conditions have the potent capacity to alter cellular properties that include endothelial structural and functional regulations. The disruption of endothelial barrier integrity may contribute to AGE-induced microangiopathy and macrovasculopathy. Previous studies have shown that AGEs induced the rearrangement of actin and subsequent hyperpermeability in endothelial cells (ECs). However, the mechanisms involved in this AGE-evoked EC malfunction are not well understood. This study directly evaluated the involvement of moesin phosphorylation in AGE-induced alterations and the effects of the RhoA and p38 MAPK pathways on this process. Using immortalized human dermal microvascular ECs (HMVECs), we first confirmed that the ezrin/radixin/moesin (ERM) protein moesin is required in AGE-induced F-actin rearrangement and hyperpermeability responses in ECs by knockdown of moesin protein expression with small interfering RNA. We then detected AGE-induced moesin phosphorylation by Western blot analysis. The mechanisms involved in moesin phosphorylation were analyzed by blocking AGE receptor binding and inhibiting Rho and MAPK pathways. AGE-treated HMVECs exhibited time-and dose-dependent increases in the Thr 558 phosphorylation of moesin. The increased moesin phosphorylation was attenuated by preadministrations of AGE receptor antibody, Rho kinase (ROCK), or p38 inhibitor. Suppression of p38 activation via the expression of dominant negative mutants with Ad.MKK6b or Ad.p38␣ also decreased moesin phosphorylation. The activation of the p38 pathway by transfection of HMVECs with an adenoviral construct of dominant active MKK6b resulted in moesin phosphorylation. These results suggest a critical role of moesin phosphorylation in AGE-induced EC functional and morphological regulations. Activation of the ROCK and p38 pathways is required in moesin phosphorylation. vascular permeability; receptor for advanced glycation end products; Rho kinase; mitogen-activated protein kinase; ezrin/radixin/moesin
phosphorylation of moesin. The increased moesin phosphorylation was attenuated by preadministrations of AGE receptor antibody, Rho kinase (ROCK), or p38 inhibitor. Suppression of p38 activation via the expression of dominant negative mutants with Ad.MKK6b or Ad.p38␣ also decreased moesin phosphorylation. The activation of the p38 pathway by transfection of HMVECs with an adenoviral construct of dominant active MKK6b resulted in moesin phosphorylation. These results suggest a critical role of moesin phosphorylation in AGE-induced EC functional and morphological regulations. Activation of the ROCK and p38 pathways is required in moesin phosphorylation. vascular permeability; receptor for advanced glycation end products; Rho kinase; mitogen-activated protein kinase; ezrin/radixin/moesin ADVANCED GLYCATION END PRODUCTS (AGEs) are formed irreversibly in serum and tissue as the result of a chain of chemical nonenzymatic reactions (35) . The accumulation of AGEs in vivo has been found to increase with age and to occur at an accelerated rate in subjects with particular pathological conditions (10, 33) . Especially, AGEs have been found to play an important role in the development of diabetes, where levels of AGEs are correlated with the severity of complications elicited (11, 27, 28, 39) . Deposited AGEs may have the capacity to alter cellular properties by a number of mechanisms. Direct effects of AGEs in the extracellular space include the formation of cross links that may also trap neighboring unrelated macromolecules. Furthermore, AGE and receptor for AGEs (RAGE) signaling exert complex effects on cellular functions via complicated transduction pathways, such as p21 Ras, MAPKs, and NF-B in endothelial cells (ECs), monocytes, and vascular smooth muscle cells (3, 32, 40) . Our previous study (13) has demonstrated that AGEs significantly altered endothelial F-actin cytoskeleton morphology and increased EC monolayer permeability through the activation of the p38 MAPK signaling pathway. However, there is still a missing link between kinases and cytoskeleton since those signals do not directly act on F-actin and other cytoskeletal molecules. Ezrin/radixin/moesin (ERM) proteins are emerging as the potential candidates that are likely to mediate this process. Serving as cross linkers between actin filaments and the plasma membrane, ERM molecules are engaged in cell adhesion, microvilli formation, cell motility, etc. (21, 25) .
Since moesin is the main ERM molecule expressed by the endothelium (4, 18) , the present study focused on the effects of moesin in mediating the AGE-induced interaction of signaling molecules and the cytoskeleton in ECs. ERM proteins are highly homologous in their primary structures and functions, but those structures allow variable protein-protein interactions (7) . The COOH-terminal domain may form an intramolecular band to the NH 2 -terminal four-point-one ERM homology domain or may bind to F-actin depending on the phosphorylation state of a conserved threonine residue (Thr  567 in ezrin, Thr   564 in radixin, and Thr 558 in moesin). On the basis of an in vitro study (23) , it was suggested that the phosphorylation of the threonine residue suppresses the intramolecular binding. Rho kinase (ROCK) and p38 MAPK have been postulated to phosphorylate this residue, although the identity of the kinase(s) that directly phosphorylates moesin remains to be clearly defined (19, 20, 29, 41) . This study tested the hypothesis that moesin is phosphorylated on this critical threonine residue by AGE-induced signaling events and plays an important role in modulating the endothelial cytoskeleton arrangement and barrier function. Zhu et al. (42) . Adenoviruses were kindly provided by Dr. Han Jiahuai (Scripps Research Institute, La Jolla, CA).
MATERIALS AND METHODS

Materials
Preparation of AGE-modified human serum albumin. AGE-modified human serum albumin (AGE-HSA) was prepared according to the protocol of Hou et al. (15, 16) . Briefly, HSA (150 mmol/l, pH 7.4) was incubated in PBS with D-glucose (250 mmol/l) at 37°C for 8 wk. Control albumin was incubated without glucose. At the end of the incubation period, both solutions were extensively dialyzed against PBS and purified. The endotoxin content was detected by a Limulus amebocyte lysate assay (Sigma) and was found to be Ͻ500 U/l in both solutions. AGE-specific fluorescence was determined using ratio spectrofluorometry. AGE-HSA contained 70.2 U/mg protein of AGEs, whereas native albumin contained 0.9 U/mg protein of AGEs.
Cells and culture conditions. The human dermal microvascular ECs (HMVECs) from an immortalized HMVEC cell line were purchased from Cell Applications (San Diego, CA) (30). Cells were grown on 100-mm dishes or six-well plates and maintained in MCDB 131 medium containing with EC growth supplements, 10% FCS, and 2 mmol/l L-glutamine at 37°C in a humidified atmosphere containing 5% CO2.
siRNA-mediated knockdown of moesin in HMVECs. Transfection was performed according to the protocols provided by the manufacturer with slight modifications. Briefly, HMVECs were transfected with optimized concentrations of either human moesin siRNA, control nonsense siRNA, or with mock conditions using siRNA transfection reagent alone. Forty-eight hours after transfection, cells were lysed, and mRNA was extracted and subjected to RT-PCR to evaluate moesin mRNA expression. Whole cell lysates were subjected to Western blot analysis with anti-moesin antibody to confirm siRNAmediated knockdown in moesin expression.
RNA extraction and RT-PCR. Total RNA was isolated from HMVECs using TRIzol reagent (Invitrogen, Life Technologies) according to the manufacturer's protocol. RT-PCR amplification was performed with moesin-specific primers [moesin (h)-PR, Santa Cruz Biotechnology]. Two microliters of RNA at a concentration of 0.5 g/l were used as templates for cDNA synthesis in the reverse transcriptase reaction. After an initial 4-min denaturation at 95°C, cDNA was amplified for 30 cycles and then annealed at 58°C for moesin and GAPDH. At the end of the annealing process, 2 min of the elongation phase was followed by a single extension phase of 3 min at 72°C. PCR products were separated on 1.5% agarose gels.
Stimulation. In all experiments, HMVECs were grown to 90% confluence and starved for 2 h before being stimulated with AGE-HSA at the indicated doses and times. The preferences of effective concentrations of AGE-HSA were based on our previous studies (13, 38) in freshly cultured primary human umbilical vein ECs and were consistent with those from Talmor et al. (31) . In the case of receptor antibody or inhibitor (Y-27632, PD-203580, or SB-203580) treatment, HMVECs were pretreated with 100 mg/l RAGE antibody for 1 h or 25 mol/l inhibitor for 30 min and then cultured in fresh complete medium with 50 or 100 mg/l AGE-HSA for 1 h. Cells were then harvested, and proteins were extracted.
Endothelial monolayer permeability assay. Endothelial monolayer permeability was measured as described by Tinsley et al. (34) . ECs were grown to confluence on 1% gelatin-coated transwell-clear polyester membranes (Corning Costar, Acton, MA). Cells were exposed to different reagents as indicated before being subjected to 100 mg/l AGE-HSA. The tracer protein TRITC-albumin (1 g/l) was then added to the upper chambers for 45 min. Samples were collected from both the upper (luminal) and lower (abluminal) chambers for fluorometry analysis. Albumin concentrations were detected using a HTS 7000 microplate reader (Perkin-Elmer, Yokohama, Japan) with a standard curve. The permeability coefficient for albumin (Pa) was calculated as follows: Western blot analysis. Total cellular extracts from AGE-treated cells were prepared by lysing and sonicating the cells in lysis buffer [20 mmol/l Tris (pH 7.4), 2.5 mmol/l EDTA, 1% Triton X-100, 1% deoxycholic acid, 0.1% SDS, 100 mmol/l NaCl, 10 mmol/l NaF, 1 mmol/l Na 3VO4, and an anti-protease cocktail pill]. Samples were subjected to SDS-PAGE, and proteins were transferred to polyvinylidene difluoride membranes. Blots were blocked with 5% BSA in PBS containing 0.5% Tween 20 (PBS-T) for 1 h and then incubated with a 1:1,000 dilution of the primary antibody of interest overnight at 4°C on a rocker. After being washed three times for 5 min each with PBS-T, blots were incubated with a 1:1,000 dilution of horseradish peroxidase-conjugated species-specific respective secondary antibody (Dako, Ely, UK ) for 1 h at room temperature. After being washed three times for 5 min each with PBS-T, protein bands were visualized by chemiluminescence.
Fluorescent staining. ECs were plated in gelatin-coated glassbottom microwells (MatTek) and cultured to confluence. After the appropriate treatments, cells were fixed and permeated for 15 min at room temperature in PBS with 3.7% formaldehyde and 0.5% Triton X-100. Cells were blocked in 5% BSA in PBS for 1 h and subsequently incubated with moesin or p-moesin antibody at room temperature for 2 h. After a thorough wash in PBS, cells were stained with FITC-conjugated secondary antibody (Zymed, San Francisco, CA). For F-actin staining, cells were incubated with rhodamine-phalloidin (2,000 U/l) for 40 min at room temperature. Finally, cells were washed three times with PBS, mounted to allow observation, and imaged with a Leica TCS SP2 laser confocal scanning microscope (Wetzlar, Germany).
Infections with adenovirus constructs. Recombinant adenovirus constructs were generated as previously described (24, 37) . Briefly, we used Ad.MKK6b(E), the constitutively active form of MKK6 encoded by a recombinant adenovirus, and Ad.MKK6(A), the constitutively negative form of MKK6, and inactive forms of the different p38 isoforms to activate or block the p38 MAPK pathway. Cells were seeded in 100-mm dishes to confluency before the infection with adenoviruses. Cells were then incubated for 24 h before being exposed to AGE-HSA.
Data analysis and statistical methods. Data were normalized to control and are reported as percentages of the basal value in means Ϯ SD of at least three independent experiments. Data were analyzed using one-way ANOVA followed by post hoc comparisons. The level of statistical significance was taken as P Ͻ 0.05.
RESULTS
Knockdown of moesin using siRNA suppressed the AGEinduced endothelial response. Our previous study (13) showed that AGE-HSA significantly evoked an endothelial response with F-actin stress fiber formation and a decrease in EC barrier function in human umbilical vein ECs. To evaluate the role of moesin in these responses, siRNA targeting moesin and control siRNA were used in HMVECs. Treatment with siRNA against moesin inhibited moesin mRNA expression in HMVECs but had no effect on the expression of GAPDH (Fig. 1A) . Treatment with moesin siRNA also efficiently inhibited the protein expression of moesin and ERM in HMVECs but had no effect on ␤-actin expression (Fig. 1B) . This result is consistent with the report that moesin is the major ERM protein expressed by ECs, because treatment with moesin siRNA in total ERM expression caused the same decrease as in moesin.
The role of moesin in modulating EC responses induced by AGEs was then examined by comparing the distribution of F-actin in ECs as well as the fluxes of albumin across the EC monolayer between control siRNA and moesin siRNA treatments. Without the stimulation of AGE-HSA, the organization of F-actin in moesin siRNA-treated ECs was similar to control ECs (Fig. 2, A and B) . Exposure of control siRNA-treated ECs to 50 mg/l AGE-HSA for 1 h caused a shift in the F-actin distribution from a web-like structure to polymerized stress fibers (Fig. 2C) . However, this change was prevented in ECs treated with siRNA against moesin (Fig. 2D) . These results indicate that moesin protein is required in this F-actin rearrangement process. To further address the role of moesin in increasing endothelial permeability by AGE-HSA, a transwell system was used to examine the fluxes of albumin across the HMVEC monolayer. In each group, ECs were treated with either control buffer, 100 mg/l HSA, or 100 mg/l AGE-HSA for 1 h before TRITC-labeled albumin was added to the top Fig. 2 . Downregulation of the expression of moesin by siRNA prevented AGE-induced cytoskeletal changes and permeability increases. A-D: the effect of moesin siRNA on the distribution of F-actin in the cytoskeleton before or after AGE-HSA treatment. ECs treated with control or moesin siRNA were treated with either buffer or 50 mg/l AGE-HSA for 1 h, and F-actin in the cytoskeleton was examined using confocal microscopy. A: control siRNA; B: moesin siRNA; C: control siRNA ϩ AGE-HSA; D: moesin siRNA ϩ AGE-HSA. Scale bar ϭ 30 m. E: the effect of moesin siRNA on AGEinduced increases in the fluxes of albumin across ECs. TRITC-labeled albumin was added to the top chamber, and the amount of albumin appearing in the top and bottom chambers was measured. ECs seeded on filters were treated with either control or moesin siRNA. ECs were then stimulated with either buffer or 100 mg/l AGE-HSA for 1 h before the concentration of albumin was measured. Transfection with moesin siRNA decreased the hyperpermeability induced by AGE-HSA. Permeability of albumin (Pa) values are shown as percentages of control (means Ϯ SD; n ϭ 4 for each sample). *P Ͻ 0.05 compared with no AGE-treated control; #P Ͻ 0.05 compared with the corresponding samples treated with AGE-HSA only. Fig. 1 . Knockdown of moesin expression in human dermal microvascular endothelial cells (HMVECs) with small interfering (si)RNA. ECs were either untreated (U) or treated with control siRNA (C) or siRNA targeting moesin. A: cells were harvested 48 h after transfection and then lysed, and mRNA was extracted and subjected to RT-PCR to evaluate moesin mRNA expression. B: the effect of siRNA on the protein expression of moesin, ezrin/radixin/moesin (ERM), or ␤-actin was examined using Western blot analysis. C: ECs were either untreated or treated with control siRNA or siRNA targeting moesin. ECs were then stimulated with 50 mg/l advanced glycation end product (AGE)-modified human serum ablumin (AGE-HSA) for 1 h. The effect of siRNA on the protein expression of phosphorylated (p-)moesin or ␤-actin was examined using Western blot analysis. Data are presented as fold changes over the buffer or AGE-treated control after normalization by ␤-actin level and are presented as means Ϯ SD; n ϭ 3 for each sample. *P Ͻ 0.05 compared with buffer-treated controls.
wells. The EC monolayer treated with control buffer or moesin siRNA alone had a similar permeability to albumin (Fig. 2E) . In response to AGE-HSA stimulation, ECs treated with control siRNA showed a significant increase in the permeability to albumin, whereas this increase was notably attenuated by moesin siRNA treatment. These data indicate that moesin is essential for the AGE-induced increase in EC monolayer permeability.
AGEs induced threonine phosphorylation of moesin and ERM proteins in HMVECs. After the essential role of moesin in AGE-induced EC responses was confirmed by suppressing moesin expression, the effect of AGEs on the threonine phosphorylation of moesin in confluent ECs was then examined. Treatment of HMVECs with 50 mg/l AGE-HSA resulted in a significant increase in moesin phosphorylation in a time-dependent manner (Fig. 3A) . A dose-response experiment indicated that a notable increase of moesin phosphorylation appeared in applications of AGE-HSA at 50 mg/l for 1 h (Fig.  3B) . Incubation of HMVECs with HSA alone had no effect on moesin threonine phosphorylation. AGE-induced moesin phosphorylation also significantly diminished in ECs pretreated with moesin siRNA (Fig. 1C) . Furthermore, threonine phosphorylation of ERM proteins was also estimated by immunoblot analysis with p-ERM [ezrin (Thr 567 )/radixin (Thr 564 )/ moesin (Thr 558 )] antibody. Increases in ERM threonine phosphorylation induced by AGE-HSA were also detected in timeand concentration-dependent patterns (Fig. 4) .
The distribution of p-moesin in ECs was then examined by immunological fluorescent staining. p-Moesin was localized primarily at the cell periphery without AGE-HSA treatment (Fig. 5A) . Treatment of the cells with AGE-HSA induced an increase in the density of fluorescent staining of p-moesin, consistent with the Western blot experiments. p-Moesin was presented in the cytoplasm of ECs and formed polymerized sarciniform fibers after the administration of 50 mg/l AGE-HSA for 1 h (Fig. 5B) . The distribution of total moesin within these ECs was not altered by AGE-HSA (data not shown).
It has been shown that moesin phosphorylation is involved in TNF-␣-evoked responses in pulmonary microvascular ECs (18) . To exclude the possibility of LPS-induced TNF-␣ contamination in this AGE-HSA application, a specific antibody for neutralizing TNF-␣ was added at doses of 25 mg/l to AGE-HSA solution 4 h before being applied to ECs. The results showed no differences in moesin phosphorylation and EC monolayer permeability between groups with or without TNF-␣ antibody (Fig. 6, A and B) .
Involvement of RAGE in AGE-induced moesin phosphorylation.
To test the role of RAGE in AGE-induced moesin phosphorylation, HMVECs were pretreated with 100 mg/l RAGE antiboy (anti-RAGE IgG) 1 h before exposure to 50 mg/l AGE-HSA for another 1 h. RAGE antibody blocked AGE-induced moesin phosphorylation and rearrangement in the cytoplasm (Figs. 7 and 5C ). Furthermore, pretreatment of HMVECs with 100 mg/l RAGE antibody for 1 h also attenuated the 100 mg/l AGE-induced elevation in the permeability of albumin (Fig. 8B) . These data suggest that binding of AGEs to RAGE plays an important role in the mediation of AGEinduced moesin phosphorylation and the increase of vascular permeability.
Involvement of the ROCK and p38 MAPK pathways in AGE-induced moesin phosphorylation.
To elucidate the signal pathways that might be involved in AGE-induced moesin phosphorylation, HMVECs were pretreated with 25 mol/l ROCK inhibitor Y-27632 and MAPK inhibitors SB-203580, PD-98059, or SP-600125, respectively, before being exposed to 50 mg/l AGE-HSA. Moesin threonine phosphorylation and the morphological rearrangement in ECs were remarkably prevented by Y-27632 or SB-203580, whereas ERK or JNK inhibition with PD-98059 or SP-600125, respectively, did not attenuate this AGE-evoked alteration (Figs. 8A and 5 , D and E). The inhibition of the ROCK and p38 MAPK pathways could also obviously attenuate the AGE-induced increases in EC monolayer permeability (Fig. 8B) . The roles of ROCK and p38 MAPK were then further confirmed by the results showing that AGE-HSA treatment did significantly induce phosphorylations of ROCK and p38 proteins in HMVECs (Fig. 9 A and   B ). This evidence confirms the specific effects of those kinases on AGE signaling pathways.
Constructs of the dominant negative mutation of the p38 upstream kinase MKK6b, [MKK6b(A)] were used to further specify the role of the p38 MAPK pathway on AGE-induced endothelial barrier dysfunction. The results showed that the blockade of the p38 pathway by MKK6b(A) abolished AGEinduced threonine phosphorylation and the relocalization of moesin in ECs and the hyperpermeability response in the EC monolayer (Figs. 10 and 5G) , whereas the activation of the p38 pathway by a construct of the constitutive active mutation of MKK6b [MKK6b(E)] sufficiently mimicked EC alterations induced by AGE-HSA application (Figs. 10A and 5F ). The p38 isoforms participating in AGE-induced moesin phosphorylation were then identified by preinfecting ECs with adenoviruses of constructs of the dominant negative form of p38-␣ or p38-␤, respectively, 24 h before the addition of AGE-HSA. The results demonstrated that the suppression of p38-␣ activation remarkably eliminated AGE-mediated moesin threonine phosphorylation and barrier dysfunction in ECs, whereas the inhibition of p38-␤ activation showed no effect on AGEinduced endothelial malfunction (Figs. 10 and 5, H and I). The activation of MKK6b by MKK6b(E) transfection mimicked the effects of AGEs on ECs, and this mimicry was blocked by p38-␣ but not p38-␤ suppression. There have been several studies showing that there is a cross-talk between the Rho/ROCK and p38 MAPK pathways, and most of the reports have demonstrated that ROCK is the upstream regulator of p38 MAPK activation (5, 22) . In the present study, the inhibitory effect of the hyperpermeability response by the ROCK inhibitor Y-27632 plus the p38 inhibitor SB-203580 was strengthened but not additive (Fig. 8B ).
DISCUSSION
Our study first confirmed the participation of moesin in the AGE-induced EC response by knockdown of moesin expression with siRNA. The inhibition of moesin expression could attenuate the formation of F-actin stress fibers and the hyperpermeability response in AGE-stimulated HMVECs. AGEs induced the phosphorylation of moesin and ERM proteins on the conserved threonine residue in a time-and concentrationdependent manner. Moesin phosphorylation requires AGE- induced signaling pathways that include the binding of AGE-RAGE and activations of ROCK and p38 MAPK.
Our previous studies (13, 38) have shown that ECs responded to AGE-HSA stimulation by reorganization of Factin, disruption of vascular-endothelial-cadherin-composed adherence junctions, and an increase of monolayer permeability through mechanisms that include AGE-RAGE binding and activation of ROCK and p38 pathways. Serving as cross linkers between the cytoskeleton and plasma membrane, ERM proteins mediate signal molecules and cytoskeletal protein interactions through binding sites for membrane molecules on the NH 2 terminus and actin-binding sites on the COOH terminus (25, 9). Data from this study first confirmed that the involvement of moesin was critical for AGE-induced EC functional alteration by showing that the AGE-stimulated redistribution of F-actin and increase of albumin fluxes were suppressed in ECs treated with moesin siRNA (Fig. 2) . Whereas moesin is primarily found in ECs (4), the PKAmediated moesin dephosphorylation is important in transforming growth factor-␤-inhibited membrane-associated proteinmediated EC barrier protection against thrombin stimulation (8) . Koss et al. (18) have shown that TNF-␣ increased permeability in human pulmonary microvascular ECs by phosphorylating ERM proteins. Consistent with those experiments, the present study also indicates that threonine phosphorylations of Fig. 9 . AGEs induced the activation of ROCK and p38 MAPK in ECs. A: phosphorylation of ROCK was examined by Western blot analysis using Abs that recognize p-ROCK and total ROCK 30 min after 50 mg/l AGE-HSA or HSA treatment. B: phosphorylation of p38 MAPK was examined by Western blot analysis using Abs that recognizes p-p38 or total p38 30 min after 50 mg/l AGE-HSA or HSA treatment. AGEs induced the activation of p38 MAPK in ECs. Western blot data are presented as fold changes in phosphorylated protein over buffer-treated control after normalization by ␤-actin level (means Ϯ SD; n ϭ 3 for each sample). Fig. 10 . Inhibiton of the p38 MAPK pathway attenuated AGE-induced moesin phosphorylation and the permeability increase. A: confluent HMVECs were preincubated with diluent or preinfected with MKK6b(E), MKK6b(A), p38-␣(A), or p38-␤(A) for 24 h, followed by treatment with either diluent or 50 mg/l AGE-HSA for 1 h or coinfected with MKK6b(E) plus p38-␣(A) or p38-␤(A) for 24 h, followed by treatment with diluent for 1 h. The dominant negative forms of MKK6b and p38-␣ significantly reduced AGE-induced moesin phosphorylation, whereas the increased phosphorylation of moesin elicited by MKK6b(E) was eliminated by coinfection with p38-␣(A). Western blot data are presented as fold changes in phosphorylated protein over buffertreated control after normalization by ␤-actin level (means Ϯ SD; n ϭ 4 for each sample). B: the dominant negative forms of MKK6b and p38-␣ significantly reduced 100 mg/l AGE-induced hyperpermeability in HMVECs for 1 h. Pa values (means Ϯ SD; n ϭ 4 for each sample) are shown as percentages of control (no virus, no AGE-HSA). *P Ͻ 0.05 compared with no AGE-treated control; #P Ͻ 0.05 compared with the corresponding samples treated with AGE-HSA only; §P Ͻ 0.05 compared with the corresponding samples treated with MKK6b(E) only.
ERM, especially moesin, in ECs play a linker's role between AGE-evoked signaling and cytoskeleton F-actin. The results showed that phosphorylated moesin was presented only in the cellular cortex area in a quiescent state and that AGE-HSA treatment provoked the formation of a large bundle of polymerized p-moesin in the cytoplasm (Fig. 5) . With the use of a single antibody that recognizes any of the three ERM proteins when they are phosphorylated on the threonine residue [ezrin (Thr 567 )/radixin (Thr 564 )/moesin (Thr
558
)], we also found that, in addition to moesin phosphorylation, ERM proteins were also phosphorylated by AGE application (Fig. 4) . These data are the first to demonstrate the involvement of moesin and ERM phosphorylation in AGE-induced endothelial responses. The fact that TNF-␣ neutralization did not alter this moesin phosphorylation and hyperpermeability responses rules out the possibility of LPS contamination and its subsequent TNF-␣ induction (Fig. 6) .
It is well known that AGEs exert their cellular effects by binding with their specific receptors to trigger subsequent signaling pathways (3, 11) . With the use of an antibody against RAGE, the best-characterized receptor for AGEs, we (13, 38) have previously demonstrated that the activation of ECs requires the involvement of RAGE. In this study, the blockade of AGE-RAGE binding by anti-RAGE IgG restrained the AGEinduced moesin phosphorylation and its subsequent hyperpermeability in ECs (Figs. 7 and 8B) , showing again the importance of AGE-receptor binding in this sustained cellular activation process. However, the blockade of RAGE-AGE binding in this study only partially inhibited moesin phosphorylation and permeability responses. The reason for this limitation might be related to the fact that some other AGE-binding receptors, such as scavenger receptors types I and II, oligosaccharyl transferase-48 (AGE receptor 1), 80K-H phosphoprotein (AGE receptor 2), or galectin-3 (AGE-receptor 3), are also found in ECs (33) .
The kinases that phosphorylate moesin and ERM proteins have been well elucidated in several experiments, and the participants include Rho-ROCK (14, 20, 23) , p38 MAPK (19) , and PKC (18), etc. Rho GTPases play a central role in the function of the EC cytoskeleton, and ERM proteins act both upstream and downstream of Rho GTPases, which suggests the existence of a positive feedback loop between the two types of proteins (17) . We (36) have shown in another study that Rho GTPases and ROCK are both phosphorylated by AGE stimulation and that the suppression of ROCK activity by different inhibitors (H-1152 or Y-27632) could attenuate AGE-triggered hyperpermeability responses in ECs. This study confirmed again that ROCK phosphorylation activity was enhanced after exposure to AGEs for 30 min, 15 min ahead of the moesin phosphorylation in timing (Fig. 9A) . The ROCK inhibitor Y-27632 remarkably diminished AGE-induced moesin phosphorylation (Fig. 8A) . In addition to the fact that regardless of the downregulation of moesin expression ROCK was still phosphorylated by AGEs in ECs treated with moesin siRNA (data not shown), the results not only indicate that Rho-ROCK is relayed upon upstream of moesin phosphosrylation in this study but also emphasize the importance of moesin protein in this AGE-relating signaling transduction process, whereas the knockdown of moesin expression abolished AGE-induced EC responses even when ROCK was activated.
MAPKs represent the major signaling system that transduce a variety of extracellular signals through a cascade of intracellular protein phosphorylation processes. MAPKs play an important role in the regulations of cell growth, differentiation, apoptosis, and cellular responses to environmental stress (1, 6) . In mammals, four major subgroups of MAPK superfamily members have been identified: ERK, JNK, p38 MAPK, and ERK 5 (2, 12) . One of the important downstream signals triggered by AGE-RAGE binding is p38 MAPK (26, 40) . Our previous study (13) has also shown that AGE application caused the activation of p38-␣ MAPK and subsequent stress fiber formation and higher permeability in ECs. Because the threonine phosphorylations of ERM proteins have also been related to MAPK activation (18, 19) , it is reasonable to estimate that AGE-induced phosphorylations of moesin and ERM are mediated by MAPKs. We specified p38 MAPK as the critical subgroup of MAPKs by screening for the effects of MAPKs on AGE-triggered moesin phosphorylation with different inhibitors of the p38, ERK, and JNK pathways (Fig. 8A) . With the use distinct adenoviruses to negatively or actively regulate the activities of upstream or downstream molecules of the p38 pathway, this study further clarified that p38-␣ was the most distinguishing subtype involved in moesin phosphorylation upon AGE stimulation in ECs. Moesin phosphorylation was increased under either the activation of MKK6b by a construct of the constitute active form or the administration of AGEs, and these increases were all abolished by the construct of the dominated negative form of p38-␣ but not p38-␤ (Fig.  10A) . The resultant hyperpermeability response in ECs to AGE stimulation was also attenuated by p38-␣ downregulation with its dominated negative expression (Fig. 10B ).
There have been several studies showing that there is a cross talk between the Rho/ROCK and p38 MAPK pathways, and most of the reports have demonstrated that ROCK is the upstream regulator of p38 MAPK activation (5, 22) . Although we showed in this study that there was an additive attenuated effect on monolayer permeability when the activities of ROCK and p38 MAPK were both inhibited (Fig. 8B) , a lot more evidence is needed to clearly clarify the complicated relationship between Rho-ROCK and p38 MAPK in these AGEinduced EC responses.
While we emphasized the important effects of ROCK and p38 MAPK in this AGE-induced moesin phosohorylation, it is noticeable that the inhibition of ROCK and p38 MAPK only partially attenuated those responses. It has been indicated that other pathways might be involved in moesin phosphorylation. Koss et al. (18) demonstrated that PKC is involved in TNF-␣-induced moesin phosphorylation. It would be interesting to investigate whether PKC and other signal molecules also participate in AGE-triggered alterations in ECs.
In summary, the present study demonstrates that by binding to its specific receptor, RAGE, AGEs elicit a complex signaling system that includes the activation of ROCK and p38-␣ MAPK. These kinases then phosphorylate the threonine residues of moesin and ERM proteins and lead to the linking of activated moesin and ERM with F-actin, resulting in the reorganization of the cytoskeleton and disruption of endothelial barrier function. This study is the first to elucidate the important role of moesin and ERM proteins in AGE-evoked morphological and functional alteration in ECs.
